Volume 10, Number 1—January 2004
Research
Escherichia coli Producing CTX-M-2 β-Lactamase in Cattle, Japan
Table 2
MIC (μg/mL) for E. coli strain: | |||||
---|---|---|---|---|---|
Antimicrobial drug | GS528 | CSH2 trGS528 | GS554 | CSH2 trGS554 | CSH2 |
Piperacillin | >64 | >64 | >64 | >64 | <16 |
Cefotaxime | >128 | >128 | >128 | >128 | <0.5 |
Cefotaxime + CLAb | <0.12 | <0.12 | 32 | 32 | <0.12 |
Ceftazidime | 2 | 4 | 32 | 32 | <0.5 |
Ceftazidime + CLA | <0.12 | <0.12 | 16 | 32 | <0.12 |
Aztreonam | >64 | 64 | >64 | 64 | <0.5 |
Ceftriaxone | >64 | >64 | >64 | >64 | <0.5 |
Cefpodoxime | >64 | >64 | >64 | >64 | <0.5 |
Cefepime | >32 | >32 | >32 | >32 | <1 |
Cefotetan | <0.5 | <0.5 | >32 | >32 | <0.5 |
Cefmetazole | 1 | 1 | >16 | >16 | 1 |
Cefoxitin | <2 | <2 | >32 | >32 | <2 |
Meropenem | <0.5 | <0.5 | 8 | 4 | <0.5 |
Ceftiofur | >1,024 | >1,024 | >1,024 | >1,024 | <0.25 |
aE. coli CSH2 trGS528 and trGS554 were transconjugants of E. coli GS528 and GS554, respectively.
bCLA, clavulanic acid at a fixed concentration of 4 μg/mL.
Page created: December 21, 2010
Page updated: December 21, 2010
Page reviewed: December 21, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.